Navigation Links
Oncolytics Biotech Inc. Announces 2008 First Quarter Results


Cash provided by financing

activities - 12,068,172 96,253,751


Net increase in cash and cash

equivalents during the period 611,610 7,833,768 7,326,706

Cash and cash equivalents,

beginning of the period 6,715,096 3,491,511 -



Cash and cash equivalents,

end of the period 7,326,706 11,325,279 7,326,706



See accompanying notes

Oncolytics Biotech Inc.


March 31, 2008 (unaudited)


Oncolytics Biotech Inc. (the "Company" or "Oncolytics") was incorporated

on April 2, 1998 under the Business Corporations Act (Alberta) as 779738

Alberta Ltd. On April 8, 1998, the Company changed its name to Oncolytics

Biotech Inc.

The Company is a development stage biopharmaceutical company that focuses

on the discovery and development of pharmaceutical products for the

treatment of cancers that have not been successfully treated with

conventional therapeutics. The product being developed by the Company may

represent a novel treatment for Ras mediated cancers which can be used as

an alternative to existing cytotoxic or cytostatic therapies, as an

adjuvant therapy to conventional chemotherapy, radiation therapy, or

surgical resections, or to treat certain cellular proliferative disorders

for which no current thera

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
(Date:10/8/2015)... -- ATCC, the premier global biological materials resource and standards ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF) ... biotechnology organizations committed to speed a cure for Parkinson,s ... , and more than 5 million worldwide, have Parkinson,s ... , and more than 5 million worldwide, have Parkinson,s ...
(Date:10/8/2015)... 2015 The 2015 Nobel Prize in Chemistry ... at Dallas. Aziz Sancar , who earned his PhD ... in 1977, is one of three scientists who received the ... repair damaged DNA on a molecular level.  --> Aziz ... from UT Dallas in 1977, is one ...
(Date:10/8/2015)... 2015  Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... within its Applied Diagnostics and Testing business segment ... product line with ten certified Snap-N-Spike ® ... and their stable-labeled internal standards. These new solution ... taurocholic acid and native and deuterium-labeled analogs of ...
(Date:10/7/2015)... Oct. 7, 2015 Boston Scientific ... of the Boston Scientific Connected Patient Challenge , ... the use of remote patient monitoring to enhance patient ... entrepreneurs can submit their ideas and collaborate on solutions ... ). Cambridge, MA where ...
Breaking Biology Technology:
... BOONTON, N.J. and BRUSSELS, Sept. 24 Tarsa ... Board: UGNE ) today reported preclinical ... in combination with other drugs in reducing the ... being presented at the 2010 Osteoarthritis Research Society ...
... While scientists have spent the past 40 years describing ... mammalian cell divides into two, they still haven,t agreed ... seemingly contradictory theories, which now may be reconciled by ... Lingchong You. These findings could provide insights into the ...
... Scarguard Labs, LLC, announced achieving the combined ranking of the ... the category according to Information Resources, Inc.,s data ending August 8, ... the prior year for the four week period ending August 8, ... based on dollar sales for the same four week period. ...
Cached Biology Technology:
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, ... today that it has signed a contract with the ... across the full range of sentences under the Department,s ... of the Americas. "This contract with the Virginia DOC ... the US and advances our position as a trusted ...
(Date:10/5/2015)... 5, 2015 ) ... NXT-ID, Inc. (NASDAQ: NXTD ), a biometric authentication ... --> ) releases the following ... NXTD ), a biometric authentication company focused on the ... Group ( ) releases the following ...
(Date:10/1/2015)... 2015  Biometrics includes diverse set of technologies ... such as fingerprints, eye retinas, facial patterns, voice ... technology has been constantly increasing in ... In addition to the most prominent popular method ... means of biometric authentication are rapidly gaining traction ...
Breaking Biology News(10 mins):
... vaccine principle is being developed by scientists at the University ... expected potential could help to save millions of lives ... is known, represents an advance on the original DNA vaccines ... consists of a chain of amino acids attached to a ...
... researcher Dr. Danny Reinberg was awarded a Howard Hughes ... on ant epigenetics- helping to unravel the impact lifestyle ... what ants can teach us about aging and behavior. ... species including humans, using gene regulation in ants as ...
... probably the largest contaminant of our body. That this ... has not been proven convincingly. The current Editorial of ... reflects on this and concludes that this proof ... take measures to reduce our exposure from all ...
Cached Biology News:
Request Info...
... Source: E. coli containing a clone of ... Description: Topoisomerase II alters the topological state ... helix through a transient break which generates a ... of its double-stranded DNA passage mechanism, the enzyme ...
Request Info...
... Cell Expansion Kit - Neurosphere is a system ... cell expansion as neurospheres in a serum free ... Plus Media Supplement, which has been optimized for ... al . (1996) Genes & Development 10 ...
Biology Products: